Hippo Holdings Reports Strong Q4 & Full-Year 2025 Results, Projects Significant Profitability Improvement in 2026
summarizeSummary
Hippo Holdings announced strong Q4 and full-year 2025 financial results, including significant premium growth and a return to profitability, with optimistic guidance for 2026 projecting further improvements in income and underwriting.
check_boxKey Events
-
Strong Q4 2025 Performance
Gross Written Premium increased 40% to $288 million, and Net Written Premium grew 23% to $97 million. Adjusted Net Income rose 20% to $18 million, while the Combined Ratio improved 8 percentage points to 99%, indicating an underwriting profit for the quarter.
-
Full-Year 2025 Profitability Turnaround
For the full year, Gross Written Premium increased 24% to $1.1 billion. The company reported Net Income of $58 million (including a $91 million gain on sale) and Adjusted Net Income of $18 million, a significant improvement from net losses in 2024. The Combined Ratio improved 25 percentage points to 113%.
-
Positive 2026 Guidance
Hippo projects 2026 Gross Written Premium between $1.4 billion and $1.5 billion, and Net Written Premium between $500 million and $540 million. Adjusted Net Income is guided to be $45 million to $55 million, a substantial increase from $18 million in 2025, with the Combined Ratio expected to improve further to 103%-105%.
-
Book Value Growth
Book Value per share increased 17% to $16.97 at year-end 2025, up from $14.56 at year-end 2024.
auto_awesomeAnalysis
Hippo Holdings Inc. has reported robust financial results for the fourth quarter and full year 2025, demonstrating significant operational improvements and a positive shift towards profitability. The company achieved substantial growth in Gross Written Premium (GWP) and Net Written Premium (NWP), alongside notable improvements in its Net Loss Ratio and Combined Ratio. For the full year, Hippo successfully transitioned from a net loss in 2024 to positive net and adjusted net income in 2025, driven by improved underwriting and strategic asset sales. The 2026 guidance reinforces this positive trajectory, projecting continued strong premium growth and a substantial increase in adjusted net income, indicating a solid outlook for the company's financial health and operational efficiency.
At the time of this filing, HIPO was trading at $28.85 on NYSE in the Finance sector, with a market capitalization of approximately $730.9M. The 52-week trading range was $19.92 to $38.98. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.